Cite Filings / TMCI / 0000070858-26-000302
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G

Statement of Beneficial Ownership

TREACE MEDICAL CONCEPTS, INC. · Filed 2026-05-14 · Acc 0000070858-26-000302

Documents 1

  • SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-11-16 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-05-19 4 Director acquired 30,000 shares (grant or award)
  • 2026-05-19 4 Director acquired 30,000 shares (grant or award)
  • 2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-05-14 4 Chief Executive Officer bought 153,763 shares at an average $2.44 ($375,505)
  • 2026-05-14 SCHEDULE 13G Statement of Beneficial Ownership
  • 2025-11-12 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G · Armistice Capital, LLC 9.79%
  2. 2026-11-16 SCHEDULE 13G/A · Armistice Capital, LLC 1.96%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…